Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
UBS
Colorcon
Boehringer Ingelheim
Deloitte
Cerilliant
Queensland Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018813

« Back to Dashboard

NDA 018813 describes LOTRIMIN, which is a drug marketed by Schering Plough, Schering, and Bayer Healthcare Llc, and is included in four NDAs. Additional details are available on the LOTRIMIN profile page.

The generic ingredient in LOTRIMIN is butenafine hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 018813
Tradename:LOTRIMIN
Applicant:Schering
Ingredient:clotrimazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018813

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:LOTION;TOPICALStrength1%
Approval Date:Feb 17, 1984TE:RLD:No

Expired US Patents for NDA 018813

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering LOTRIMIN clotrimazole LOTION;TOPICAL 018813-001 Feb 17, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Schering LOTRIMIN clotrimazole LOTION;TOPICAL 018813-001 Feb 17, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Schering LOTRIMIN clotrimazole LOTION;TOPICAL 018813-001 Feb 17, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Medtronic
Johnson and Johnson
Julphar
Harvard Business School
Moodys
QuintilesIMS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.